Merger Notification - Announcement according to § 10 Cartel Act
Amgen Inc.; Horizon Therapeutics PLC
BWB/Z-6179
On 16.01.2023 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Amgen Inc. (Thousand Oaks / USA) intends to acquire all of the issued and to be issued shares of and sole control over Horizon Therapeutics PLC (Dublin / Ireland).
The proposed concentration concerns pharmaceutical products. Affected industry: Manufacture of pharmaceutical preparations.
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 13.02.2023.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 14.02.2023 .